Serina Therapeutics, Inc. Q4 FY2022 Earnings Call

Serina Therapeutics, Inc. (SER)

Earnings Call FY2022 Q4 Call date: 2023-03-31 Concluded

Quarter scorecard

Revenue (derived Q4)

$8,000

-70.4% YoY

Gross margin (derived Q4)

87.5%

-8.8 pp YoY

Net income (derived Q4)